Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DelMar Pharmaceuticals Inc


Ticker Change

Company Profile for DelMar Pharmaceuticals Inc (BRRY)

DelMar Pharmaceuticals, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. DelMar Pharmaceuticals serves customers worldwide.

Contact Information

DelMar Pharmaceuticals Inc

999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Phone: 1-604-629-5989

Key Executives for DelMar Pharmaceuticals Inc (BRRY)

Jeffrey BachaChairman/President/CEO/Co-FounderScott PraillChief Financial Officer
Dennis M BrownChief Scientific Ofcr/Co-Founder

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil